Skip to Content

ROCHE 0245 ROCHE 0245 (Invirase 200 mg)

Generic Name: saquinavir

Pill with imprint ROCHE 0245 ROCHE 0245 is Green / Yellow, Capsule-shape and has been identified as Invirase 200 mg. It is supplied by Roche Laboratories.

Invirase is used in the treatment of hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Invirase 200 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for ROCHE 0245 ROCHE 0245

Invirase

Generic Name:
saquinavir
Imprint:
ROCHE 0245 ROCHE 0245
Strength:
200 mg
Color:
Green / Yellow
Size:
22.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Protease inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Roche Laboratories
Inactive Ingredients:
lactose anhydrous
microcrystalline cellulose
povidone k30
sodium starch glycolate type A potato
magnesium silicate
magnesium stearate
gelatin
water
ferric oxide red
ferric oxide yellow
ferrosoferric oxide
FD&C Blue No. 2
titanium dioxide
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
54868-3699 Physicians Total Care Inc. (repackager)

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide